|
Patient characteristics |
|||
| Characteristic |
Categories |
Number |
Percent (%) |
|
|
|||
| Vital Status |
Expired |
85 |
32.8 |
| Censored1 |
174 |
67.2 |
|
| Prior Treatment |
Progressive disease |
178 |
68.7 |
| History |
Newly diagnosed |
81 |
31.3 |
| Stage at Diagnosis |
Stage I |
56 |
21.6 |
| Stage II |
110 |
42.5 |
|
| Stage III |
46 |
17.8 |
|
| Stage IV |
34 |
13.1 |
|
| Missing |
13 |
5.0 |
|
| Age at Diagnosis |
25–35 |
26 |
10 |
| 36–45 |
72 |
27.8 |
|
| 46–55 |
88 |
33.9 |
|
| 56–65 |
66 |
25.6 |
|
| 66–75 |
7 |
2.7 |
|
|
1 Patients who reached the end of their follow-up without experiencing death. N = 259 | |||
Gupta et al. BMC Cancer 2008 8:249 doi:10.1186/1471-2407-8-249 |
|||